SCHEMBL10185637

SCHEMBL10185637

C=CC1=C(C)N(C2CCCCC2)C(=O)C1N(C(=O)Cc1cccs1)/C(C=C)=C(/C)Cl

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SIGMAR1 Q99720 1/20 0.37
▸ MAPT P10636 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ NPSR1 Q6W5P4 2/20 0.33
▸ CHRM2 P08172 1/20 0.32
▸ CHRM1 P11229 1/20 0.32
▸ CHRM3 P20309 1/20 0.32
▸ TRPM8 Q7Z2W7 1/20 0.32
▸ ALDH1A1 P00352 3/20 0.32
▸ CYP3A4 P08684 2/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ GAA P10253 1/20 0.31
▸ YAP1 P46937 1/20 0.31
▸ TEAD4 Q15561 1/20 0.31
▸ XBP1 P17861 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ CYP2C19 P33261 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10184155 0.81 SIGMAR1 (0.39) SIGMAR1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL10183787 0.77 SIGMAR1 (0.37) SIGMAR1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL10183947 0.76 SIGMAR1 (0.38) SIGMAR1MEN1KMT2AHSD17B10NPSR1
SCHEMBL10183656 0.72 SIGMAR1 (0.39) SIGMAR1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL10184045 0.64 OPRM1 (0.42) SIGMAR1MEN1KMT2AHSD17B10NPSR1
SCHEMBL10185925 0.63 MEN1 (0.39) SIGMAR1SMN1; SMN2MEN1KMT2AHSD17B10
SCHEMBL10185945 0.63 OPRM1 (0.39) SIGMAR1NPSR1CHRM2CHRM1CHRM3
SCHEMBL10183670 0.63 TRPM8 (0.41) SIGMAR1NPSR1TRPM8GAA
SCHEMBL10184154 0.62 POLB (0.39) SIGMAR1MAPTMEN1KMT2AHSD17B10
SCHEMBL18074198 0.62 SIGMAR1 (0.39) SIGMAR1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012009678-A1 THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHOD OF USE AGIOS PHARMACEUTICALS, INC. (US) 2012-01-19 — — WO disclosed
Send feedback